首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1629872

全球藥品泡殼包裝市場 - 2024-2032

Global Pharma Blisters Packaging Market - 2024-2032

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球藥品泡殼包裝市場規模達到58.3億美元，預計2032年將達到87.2億美元，2024-2032年預測期間複合年成長率為4.7%。

藥品泡殼包裝市場包括使用預成型塑膠包裝，旨在安全地容納單一劑量的藥物，例如片劑、膠囊和錠劑。此包裝解決方案透過提供有效的空氣、濕氣和污染屏障保護，對於延長藥品的保存期限至關重要。泡殼包裝通常由熱成型塑膠或鋁形成的空腔組成，通常用紙板或箔等背襯材料密封。

市場動態：

驅動程式和限制

包裝技術的創新

包裝技術的創新預計將透過提高安全性、提高患者依從性和促進永續性來顯著推動藥品泡殼包裝市場。最近的進展集中在整合智慧技術，例如感測器和追蹤設備，它們可以監控藥物使用和有效期限。

另一項重大創新是永續包裝解決方案的發展。乾模纖維 (DMF) 和紙基吸塑包裝等環保替代品正成為傳統塑膠包裝的可行替代品。這些材料既可回收又可生物分解，解決了環境問題，同時仍為藥品提供必要的保護品質。例如，2024 年 7 月，Aluflexpack 宣布開發新產品 4-Infinity Form。這款泡殼包裝專為製藥行業設計，完全由漆鋁製成，為傳統的多材料包裝提供永續且可回收的替代品。 4-Infinity Form 解決方案解決了藥品包裝產業對環境影響日益成長的擔憂。

設計的進步也使泡殼包裝更加人性化，特別是對於老年人等弱勢群體。兒童防護機制和老年人友善設計等功能可確保藥物保持安全且易於使用。例如，2024 年 11 月，Schreiner MediPharm 推出了一款新型兒童安全智慧吸塑錢包。本產品為臨床試驗提供安全、智慧的包裝解決方案。 Schreiner MediPharm 提供各種用於臨床試驗的智慧泡殼包裝。

可自訂劑量追蹤工具的引入使患者能夠輕鬆監控他們的用藥時間表，從而提高依從性並改善健康結果。總體而言，這些創新不僅增強了泡殼包裝的功能性和永續性，而且滿足了製藥業對以患者為中心的解決方案不斷成長的需求。因此，上述因素正在促進藥品泡殼包裝市場的發展。

醫療廢棄物成長率

醫療廢棄物的增加預計將成為藥品泡殼包裝市場的重要限制因素。這是由於日益增加的環境問題和監管壓力。吸塑包裝雖然可以有效保護藥物並延長保存期限，但主要由塑膠和鋁組成，這使得處理和回收工作變得複雜。

泡殼包裝中所用材料的複雜性使得它們難以回收，從而產生大量廢物，這些廢物通常最終進入垃圾掩埋場或焚化爐。這不僅會導致環境退化，還會引起消費者和監管機構對藥品包裝實踐永續性的擔憂。公司需要創新和調整其包裝策略來解決這些問題，同時遵守旨在減少浪費和促進永續性的不斷發展的法規。

The pharmaceutical blister packaging market includes the usage of pre-formed plastic packaging designed to securely hold individual doses of medications, such as tablets, capsules, and lozenges. This packaging solution is essential for enhancing the shelf life of pharmaceuticals by providing effective barrier protection against air, moisture, and contamination. Blister packs typically consist of a cavity formed from thermoformed plastic or aluminum, often sealed with a backing material such as paperboard or foil.

Market Dynamics: Drivers & Restraints

Innovations in packaging technology

Innovations in packaging technology are expected to significantly propel the pharma blister packaging market by enhancing safety, improving patient adherence, and promoting sustainability. Recent advancements have focused on integrating smart technologies, such as sensors and tracking devices, which can monitor medication usage and expiration dates.

Another significant innovation is the development of sustainable packaging solutions. Eco-friendly alternatives like Dry Molded Fiber (DMF) and paper-based blister packs are emerging as viable substitutes for traditional plastic packaging. These materials are both recyclable and biodegradable, addressing environmental concerns while still providing the necessary protective qualities for pharmaceutical products. For instance, in July 2024, Aluflexpack announced the development of a new product, the 4-Infinity Form. This blister pack, designed specifically for the pharmaceutical industry, is constructed entirely of lacquered aluminum, offering a sustainable and recyclable alternative to traditional multi-material packaging. The 4-Infinity Form solution addresses growing concerns about the environmental impact within the pharmaceutical packaging sector.

Advancements in design are also making blister packs more user-friendly, particularly for vulnerable populations such as the elderly. Features like child-resistant mechanisms and senior-friendly designs ensure that medications remain safe yet accessible. For instance, in November 2024, Schreiner MediPharm launched a New Child-Resistant Smart Blister Wallet. The product provides secure and smart packaging solutions for clinical trials. Schreiner MediPharm offers a wide variety of smart blister packs for clinical trials.

The introduction of customizable dosage tracking tools allows patients to easily monitor their medication schedules, thereby enhancing adherence and improving health outcomes. Overall, these innovations not only enhance the functionality and sustainability of blister packaging but also align with the growing demand for patient-centric solutions in the pharmaceutical industry. Thus, the above factors are contributing to the pharma blisters packaging market.

Growing rate of medical waste

The increasing rate of medical waste is expected to be a significant restraining factor for the pharma blister packaging market. This is due to increasing environmental concerns and regulatory pressures. Blister packaging, while effective in protecting medications and extending shelf life, is primarily composed of plastic and aluminum, which complicates disposal and recycling efforts.

The complexity of materials used in blister packs makes them challenging to recycle, resulting in a considerable amount of waste that often ends up in landfills or incinerators. This not only contributes to environmental degradation but also raises concerns among consumers and regulatory bodies regarding the sustainability of pharmaceutical packaging practices. Companies will need to innovate and adapt their packaging strategies to address these issues while complying with evolving regulations aimed at reducing waste and promoting sustainability.

Segment Analysis

The global Pharma Blisters Packaging market is segmented based on disease type, drug class, route of administration, distribution channel, end-user, and region.

Type:

Thermoformable blister packs segment is expected to dominate the global pharma blisters packaging market share

The thermoformable blister packs segment is expected to dominate the pharmaceutical blister packaging market due to several compelling factors that enhance its appeal to manufacturers and end-users alike. Thermoformable technology utilizes heat and pressure to shape plastic sheets into precisely formed cavities, allowing for intricate designs that accommodate various pharmaceutical products, including tablets and capsules, without compromising their integrity during storage and transport.

Companies are introducing various packaging solutions that are thermoformable. For instance, in November 2023, Coveris manufactured a new recyclable, flexible thermoforming film solution, called Formpeel P, for use in various medical packaging applications. The rising product innovations also contribute to the segment's growth.

One of the key advantages of thermoforming is its cost-effectiveness. Compared to cold-forming technology, thermoforming has lower initial tooling and equipment costs, making it more accessible for manufacturers looking to optimize production without incurring substantial expenses.

Geographical Analysis

North America is expected to hold a significant position in the global pharma blisters packaging market share

The North America is expected to hold a significant position in the global pharma blisters packaging market. This is due to the rising innovation in packaging solutions, increasing pharmaceutical production and consumption. The presence of a large number of packaging companies is expected to contribute to the region's market growth.

The presence of major pharmaceutical companies, including giants like Pfizer and Moderna, further solidifies North America's position in the blister packaging market. These companies not only dominate the production of high-demand pharmaceuticals but also invest heavily in research and development, leading to a continuous influx of new drug formulations that require effective packaging solutions.

The increasing focus on patient safety and adherence to medication regimens further emphasizes the need for effective packaging that can protect pharmaceuticals from environmental factors. Moreover, advancements in packaging technology are enhancing the functionality of blister packs, making them more user-friendly and sustainable. For instance, in October 2022, US-based pharmaceutical provider TekniPlex Healthcare introduced the world's first fully transparent recyclable mid-barrier blister package at Pack Expo in Chicago.

Asia Pacific is growing at the fastest pace in the global pharma blisters packaging market

Asia-Pacific is currently experiencing the fastest growth in the pharma blister packaging market. This growth is driven by the rising consumption of pharmaceutical products due to the incidence of several chronic diseases particularly in China and India, increasing pharmaceutical production by manufacturing companies, and the increasing innovations in packaging solutions.

Competitive Landscape

The major global players in the pharma blisters packaging market include ACG, KAA Timex LR, Amcor plc, Caprihans India Limited, Constantia Flexibles, Honeywell International Inc., Sonoco Products Company, The Dow Chemical Company, Tekni-Plex, Inc. and Korber AG among others.

Key Developments

In April 2022, Huhtamaki introduced a first-to-market sustainable innovation for the global pharmaceutical and healthcare industry. Huhtamaki's Push Tab(R) blister lid is mono-material PET and free from aluminum.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Pharma Blisters Packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Innovations in packaging technology
- 4.1.2. Restraints
  - 4.1.2.1. Growing rate of medical waste
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Thermoformable Blister Packs*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Face Seal Blister Packs
6.4. Full-face Seal Blister Packs
6.5. Clamshell Blister Packs
6.6. Cold-formable Blister Packs
6.7. Child-resistant Blister Packaging
6.8. Single-seal Blister Cards
6.9. Others

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. PVC (Polyvinyl Chloride) *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. PVDC (Polyvinylidene Chloride)
7.4. Polychlorotrifluoroethylene
7.5. Aluminum-Aluminum (Alu-Alu)
7.6. Cold Form Foil (CFF)
7.7. Paper & Cardboard
7.8. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Tablets*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Ampoules
8.5. Syringes
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. ACG*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. KAA Timex LR
11.3. Amcor plc
11.4. Caprihans India Limited
11.5. Constantia Flexibles
11.6. Honeywell International Inc.
11.7. Sonoco Products Company
11.8. The Dow Chemical Company
11.9. Tekni-Plex, Inc.

LIST NOT EXHAUSTIVE